Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    First randomized trial reassures on ACEIs, ARBs in COVID-19

    September 2, 2020

    The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.

  • 1
    News

    HOME-PE trial clarifies which pulmonary embolism patients to treat at home

    September 1, 2020

    “Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides

  • 1
    News

    ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments

    August 31, 2020

    The first guideline update in 5 years for non ST-elevation ACS stresses high sensitivity troponin for diagnosis and tailored antiplatelet treatments.

  • 1
    News

    Gut bacteria linked to cardiovascular, other health conditions

    August 31, 2020

    “Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of cardiovascular diseases.”

  • 1
    News

    DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes

    August 31, 2020

    DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.

  • News

    COVID-19 at home: What does optimal care look like?

    August 31, 2020

    Most attention has focused on the sickest patients, leaving less severe cases to fall through the cracks.

  • 1
    News

    EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects

    August 30, 2020

    The 25% cut in primary endpoints among HFrEF patients on empagliflozin matched the benefit seen before from dapagliflozin in DAPA-HF.

  • 1
    News

    Early rhythm control in AFib gains new life

    August 30, 2020

    EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.

  • 1
    News

    Heart failure: Practice-changing developments for hospitalists

    August 26, 2020

    “I really like this H2FPEF score. The score works very, very well” for diagnosis of HFpEF – Dr. Dustin T. Smith

  • News

    First evidence of SARS-CoV-2 in heart cells

    August 25, 2020

    SARS-CoV-2 has been found in cardiac tissue of a child with multisystem inflammatory syndrome related to COVID-19, believed to be first evidence of direct infection of heart muscle cells by the virus.

Previous1 … 25 26 27 28 29 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences